Neogene Therapeutics

Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid cancers

Founded 2018

The Netherlands 45 employees Acquired Total: $445.00M Biotechnology, Health Care +1

General Information

Company Name Neogene Therapeutics

Founded Year 2018

Location

The Netherlands

Founders / Decision Makers

Employees 45

Industries Biotechnology, Health Care, Health and Wellness

Funding Stage Acquired

Business Model B2B

Revenue Model Product Sales, Service Fee, Licensing

Social

BounceWatch is an independent company data service, not affiliated with Neogene Therapeutics. To contact Neogene Therapeutics, visit neogene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Neogene Therapeutics compare?

A PDF of Neogene Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Neogene Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is Neogene Therapeutics on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

The Netherlands Market

Market Signals All Companies

Biotechnology

Industry Signals All Companies in The Netherlands

Neogene Therapeutics Alternatives

All Signals Trend Reports

About Neogene Therapeutics

Neogene Therapeutics is a clinical-stage biotechnology company founded in 2018, dedicated to innovating next-generation engineered T cell receptor therapies aimed at treating a broad array of solid cancers. The company's slogan, "Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid cancers," underscores its mission to revolutionize cancer treatment.

With its headquarters in The Netherlands and offices in both Santa Monica, CA and Amsterdam, Neogene is strategically positioned on the global stage. As part of the AstraZeneca Group, it has access to vast resources and support, allowing it to target substantial advancements within the Biotechnology and Health Care industries.

Significant investor confidence was evident with its last investment—a $320.00M acquisition by AstraZeneca on 01 November 2022. This acquisition not only reflects the strong potential of Neogene's technologies but also establishes a robust foundation for future growth and innovation.

Business keywords: engineered T cell receptor therapies, solid cancers, neo-antigen specific TCR, cancer treatment innovation, tumor biopsies, tumor-infiltrating lymphocytes, DNA sequencing, genetic screening tools, next-generation therapies, T cell engineering, oncology, neo-antigen targeting, designer T cells

Services & Products

development of gene therapy treatments

innovative cancer therapeutics

Target Customers

healthcare providers oncologists cancer patients pharmaceutical partners

Funding Rounds & Investors (4)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Acquisition	$320.00M	1	AstraZeneca	01 Nov 2022
Series A	$110.00M	8	Polaris Partners, Pontifax +6	01 Sep 2020
Early VC	$15.00M	-		01 May 2019
Spinout	Undisclosed	1	CANCER FUND	01 Sep 2018

Latest News

View All

Neoadjuvant Therapy Trials in Melanoma: What We Have Learned

Dailynews.ascopubs.org Aug 28, 2025

And just like that... pharma’s breakups reveal pain points in cancer R&D

Pharmavoice.com Aug 22, 2025

AstraZeneca drops lead T-cell receptor therapy from $200M Neogene buy

Fiercebiotech.com Jul 29, 2025

AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D

Biospace.com Jul 29, 2025

AstraZeneca's newest CAR-T play shows first glimpse of clinical activity

Firstwordpharma.com Jul 07, 2025

Neogen® To Participate in Upcoming January 2025 Investor Conferences

Biospace.com Jan 08, 2025

Neogene Therapeutics Alternatives & Competitors

View All Alternatives

Neogene Therapeutics vs

3T Biosciences United States

3T is an immunotherapy company developing next-generation, transformative therapies for broad patien...

Series A

26 employees

Biopharma, Biotechnology

Compare Neogene Therapeutics vs 3T Biosciences

Neogene Therapeutics vs

Pyxis Oncology United States

Charting a course to therapeutics for difficult-to-treat cancer.

68 employees

Biotechnology, Health Care

Compare Neogene Therapeutics vs Pyxis Oncology

Neogene Therapeutics vs

Engimmune Therapeutics Switzerland

Engineering the next-generation of T cell receptor therapies against cancer

13 employees

Biotechnology, Health and Wellness

Also compare with:

Crossbow Therapeutics, Inc View all alternatives

FAQ About Neogene Therapeutics

Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid cancers

Neogene Therapeutics was founded in 2018.

Neogene Therapeutics is headquartered in The Netherlands.

Neogene Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on engineered T cell receptor therapies, solid cancers, neo-antigen specific TCR and cancer treatment innovation. Its customers include healthcare providers, oncologists and cancer patients.

Neogene Therapeutics has a B2B business model. Its revenue comes from Product Sales, Service Fee and Licensing.

Neogene Therapeutics has approximately 45 employees.

Neogene Therapeutics has completed 4 funding rounds, raising a total of $445.00M. The latest funding stage is Acquired.

Neogene Therapeutics offers: development of gene therapy treatments, innovative cancer therapeutics.

Top alternatives and competitors to Neogene Therapeutics include 3T Biosciences, Pyxis Oncology, Engimmune Therapeutics, Adicet Bio, Inc, Crossbow Therapeutics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Neogene Therapeutics and 3T Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neogene Therapeutics, https://bouncewatch.com/company/neogene-therapeutics, updated 25 September 2026. When citing, please name BounceWatch and link this page.